Smith, G. (2026). Blackstone Invests $250 Million in Biotech Anagram Therapeutics. Bloomberg.com, N.PAG.
Chicago Style (17th ed.) CitationSmith, Gerry. "Blackstone Invests $250 Million in Biotech Anagram Therapeutics." Bloomberg.com 2026: N.PAG.
MLA (9th ed.) CitationSmith, Gerry. "Blackstone Invests $250 Million in Biotech Anagram Therapeutics." Bloomberg.com, 2026, p. N.PAG.
Warning: These citations may not always be 100% accurate.